# Ruishixingchen Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ruishixingchen-biotechnology

- Industry: Biotechnology
- Headquarters: Hangzhou, China
- Latest round: Angel (Nov 13, 2025)
- Investors on record: 2

## About

Founded in 2024 and based in Hangzhou, China, Ruishixingchen Biotechnology is a cell technology developer specializing in the research, development, and application of cell-based technologies, providing technical support for the healthcare sector. In November 2025, Ruishixingchen Biotechnology raised an Angel funding led by returning investor Huafang Capital, with participation from new investor Hangzhou High-Tech Investment.
The company focuses on related fields through cell-based technologies, serving the needs of disease treatment and health management.
Revenue is generated through proving biotechnology service. The Angel funds raised will be used to advance the company's leading iPSC differentiated corneal endothelial cell therapy product pipeline and to develop early-stage research pipelines driven by original technologies.

## Funding rounds

- Angel, Nov 13, 2025 — Hangzhou High-Tech Investment, Huafang Capital

## Investors

- Hangzhou High-Tech Investment (https://capitalatlas.ai/funds/hangzhou-high-tech-investment) — Angel
- Huafang Capital (https://capitalatlas.ai/funds/huafang-capital) — Angel